GW&K Investment Management, LLC
Position in BCRX — Biocryst Pharmaceuticals Inc
CIK 1082917
BOSTON, MA
Position in BCRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$31,711,130
+$861,933 QoQ
Shares Held
3,171,113
-2.1% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#20
of 318 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 94%
Shared 6%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GW&K Investment Management, LLC holds $191,069,124 across 11 Drug Manufacturers - Specialty & Generic names. BCRX ranks #3 (16.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
567,421 | $95,633,135 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,037,242 | $48,242,125 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
3,171,113 | $31,711,130 | |
| 4 | ALKS |
Alkermes plc.
|
292,387 | $15,321,078 | |
| 5 | VTRS |
Viatris Inc
|
3,133 | $49,752 | |
| 6 | ZTS |
Zoetis Inc.
|
516 | $37,079 | |
| 7 | HLN |
Haleon plc
|
3,796 | $35,416 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
495 | $16,770 |
All Filings in BCRX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,711,130 | 3,171,113 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $30,849,197 | 3,240,462 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $24,655,206 | 3,160,924 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $16,681,036 | 2,197,765 | Shares | Other | 2025-11-12 | |
| 2025-06-30 | $23,506,891 | 2,623,537 | Shares | Other | 2025-08-11 | |
| 2025-03-31 | $21,635,099 | 2,884,680 | Shares | Other | 2025-05-05 | |
| 2024-12-31 | $22,119,297 | 2,941,396 | Shares | Other | 2025-02-05 | |
| 2024-09-30 | $24,909,760 | 3,277,600 | Shares | Other | 2024-11-07 | |
| 2024-06-30 | $21,041,045 | 3,404,700 | Shares | Other | 2024-08-12 | |
| 2024-03-31 | $17,545,851 | 3,453,908 | Shares | Other | 2024-05-08 | |
| 2023-12-31 | $14,002,720 | 2,337,683 | Shares | Other | 2024-02-09 | |
| 2023-09-30 | $18,201,709 | 2,570,863 | Shares | Other | 2023-11-09 | |
| 2023-06-30 | $18,291,623 | 2,598,242 | Shares | Other | 2023-08-09 | |
| 2023-03-31 | $21,716,783 | 2,603,931 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $19,826,958 | 1,727,087 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $17,855,963 | 1,417,140 | Shares | Other | 2022-11-09 | |
| No filing history on record for this holder in this stock. | ||||||